MBD-4 (11-40) / P9 [H21R,K23R,K28R], P9R

General Information


DRACP ID  DRACP04089

Peptide Name   MBD-4 (11-40) / P9 [H21R,K23R,K28R], P9R

Sequence  NGAICWGPCPTAFRQIGNCGRFRVRCCRIR

Sequence Length  30

UniProt ID  P82019 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antiviral



Structure Information


PDB ID  6M56 

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C144H232N52O35S5

Absent amino acids  DEHKLMSY

Common amino acids  R

Mass  392951

Pl  10.51

Basic residues  6

Acidic residues  0

Hydrophobic residues  9

Net charge  6

Boman Index  -7004

Hydrophobicity  -15

Aliphatic Index  55.33

Half Life 
  Mammalian: 100 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5750

Absorbance 280nm  198.28

Polar residues  12

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32843628

Title  A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16965

DRACP is developed by Dr.Zheng's team.